Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Enzymotec Appoints Steve Dubin As Chairman

RELATED NEWS
Trade ENZY now with 

Enzymotec Ltd. (ENZY: Quote), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced Thursday that it has appointed Steve Dubin as Chairman of its board of directors, effective January 1, 2014.

The company also announced that it has appointed Yoav Doppelt as Vice Chairman of the board. Doppelt has served as Chairman of Enzymotec's board of directors since October 2011 and as a director since 2001. He will continue to be an actively involved board member and will assist Dubin during the transition process.

Steve Dubin has served as Vice Chairman of Enzymotec's board of directors since April 2013. Since November 2011, Dubin has been a Principal in SDA Ventures LLC.

Dubin also acts as a Senior Advisor to Paine & Partners, LLC. From 2006 until its acquisition by Royal DSM N.V. in February 2011, Dubin served as Chief Executive Officer and a member of the board of directors of Martek Biosciences Corporation. He also served as President of DSM's Nutritional Lipids Division immediately after DSM's acquisition of Martek and as a Senior Advisor to DSM Nutritional Products from 2011 through October 2012.

Having joined Martek in 1992, he held various management positions, including Chief Financial Officer, Treasurer, Secretary, General Counsel and Senior Vice President, Business Development, as well as President of Martek from 2003 to 2006.

Dubin is a co-founder and co-manager of a Maryland-based, angel-investing club. Dubin currently serves as a member of the board of several privately held companies, including The Brain Center, LLC, MyCell Technologies and its subsidiary Oceans Omega LLC, and Alcresta, Inc. Prior to that, he was a member of the board of directors of Scerene Healthcare Inc.

Register
To receive FREE breaking news email alerts for Enzymotec Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame. India's economy grew faster-than-expected in the three months to June and at the strongest pace in two years, preliminary figures from the Central Statistics Office revealed Friday. Gross domestic product grew 5.7 percent in the April to June quarter, which exceeded economists' forecast for 5.5 percent expansion. The economy grew 4.6 percent in the previous three months. Eurozone inflation slowed as expected in August on falling energy prices giving room for the central bank to support demand and economic recovery without stoking inflation and help the region to create more jobs. The unemployment rate remained unchanged at an elevated level in July. Nonetheless, it was at the lowest since September 2012.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.